Literature DB >> 18348162

FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD).

R Hersmus1, N Kalfa, B de Leeuw, H Stoop, J W Oosterhuis, R de Krijger, K P Wolffenbuttel, S L S Drop, R A Veitia, M Fellous, F Jaubert, L H J Looijenga.   

Abstract

The transcription factors SOX9 and FOXL2 are required for male and female mammalian gonadal development. We have used specific antibodies to investigate the role of these key proteins in disorders of sex development (DSD), specifically inter-sex states. In normal gonads, SOX9 was found to be restricted to the presence of (pre-)Sertoli cells, while FOXL2 was found in granulosa cells, and in stromal cells interpreted as early ovarian stroma. Both proteins were found within a single patient, when testicular and ovarian development was present; and within the same gonad, when both differentiation lineages were identified, as in ovotesticular DSD (ie hermaphrodite). Especially SOX9 was informative to support the presence of early testicular development (ie seminiferous tubules), expected based on morphological criteria only. In a limited number of DSD cases, FOXL2 was found within reasonably well-developed seminiferous tubules, but double staining demonstrated that it was never strongly co-expressed with SOX9 in the same cell. All seminiferous tubules containing carcinoma in situ (CIS), the malignant counterpart of a primordial germ cell, ie the precursor of type II germ cell tumours of the testis, seminomas and non-seminomas, showed the presence of SOX9 and not FOXL2. In contrast, gonadoblastomas (GBs), the precursor of the same type of cancer, in a dysgenetic gonad, showed expression of FOXL2 and no, or only very low, SOX9 expression. These findings indicate that gonadal differentiation, ie testicular or ovarian, determines the morphology of the precursor of type II germ cell tumours, CIS or GB, respectively. We show that in DSD patients, the formation of either ovarian or/and testicular development can be visualized using FOXL2 and SOX9 expression, respectively. In addition, it initiates a novel way to study the role of the supportive cells in the development of either CIS or GB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348162     DOI: 10.1002/path.2335

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  32 in total

1.  A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development.

Authors:  Stefan White; Jacqueline Hewitt; Erin Turbitt; Yvonne van der Zwan; Remko Hersmus; Stenvert Drop; Peter Koopman; Vincent Harley; Martine Cools; Leendert Looijenga; Andrew Sinclair
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

2.  Antagonism of the testis- and ovary-determining pathways during ovotestis development in mice.

Authors:  Dagmar Wilhelm; Linda L Washburn; Vy Truong; Marc Fellous; Eva M Eicher; Peter Koopman
Journal:  Mech Dev       Date:  2009-03-06       Impact factor: 1.882

Review 3.  Determination and stability of gonadal sex.

Authors:  David Schlessinger; José-Elias Garcia-Ortiz; Antonino Forabosco; Manuela Uda; Laura Crisponi; Emanuele Pelosi
Journal:  J Androl       Date:  2009-10-29

Review 4.  Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure?

Authors:  Alice Faure; Aurore Bouty; Mike O'Brien; Jorgen Thorup; John Hutson; Yves Heloury
Journal:  Nat Rev Urol       Date:  2016-01-20       Impact factor: 14.432

5.  A novel SRY missense mutation affecting nuclear import in a 46,XY female patient with bilateral gonadoblastoma.

Authors:  Remko Hersmus; Bertie H C G M de Leeuw; Hans Stoop; Pascal Bernard; Helena C van Doorn; Hennie T Brüggenwirth; Stenvert L S Drop; J Wolter Oosterhuis; Vincent R Harley; Leendert H J Looijenga
Journal:  Eur J Hum Genet       Date:  2009-06-10       Impact factor: 4.246

6.  Microarray analysis of Foxl2 mediated gene regulation in the mouse ovary derived KK1 granulosa cell line: Over-expression of Foxl2 leads to activation of the gonadotropin releasing hormone receptor gene promoter.

Authors:  Jean M Escudero; Jodi L Haller; Colin M Clay; Kenneth W Escudero
Journal:  J Ovarian Res       Date:  2010-02-18       Impact factor: 4.234

7.  A clinical and molecular project on gonadoblastoma needs international collaboration.

Authors:  Nicolas Kalfa; Olivier Maillet; Charles Sultan
Journal:  Rare Tumors       Date:  2009-12-28

8.  Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte.

Authors:  Si Brask Sonne; Kristian Almstrup; Marlene Dalgaard; Agnieszka Sierakowska Juncker; Daniel Edsgard; Ludmila Ruban; Neil J Harrison; Christian Schwager; Amir Abdollahi; Peter E Huber; Søren Brunak; Lise Mette Gjerdrum; Harry D Moore; Peter W Andrews; Niels E Skakkebaek; Ewa Rajpert-De Meyts; Henrik Leffers
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

9.  Human SRY inhibits beta-catenin-mediated transcription.

Authors:  Pascal Bernard; Helena Sim; Kevin Knower; Eric Vilain; Vincent Harley
Journal:  Int J Biochem Cell Biol       Date:  2008-06-28       Impact factor: 5.085

10.  Foxl2 functions in sex determination and histogenesis throughout mouse ovary development.

Authors:  José Elias Garcia-Ortiz; Emanuele Pelosi; Shakib Omari; Timur Nedorezov; Yulan Piao; Jesse Karmazin; Manuela Uda; Antonio Cao; Steve W Cole; Antonino Forabosco; David Schlessinger; Chris Ottolenghi
Journal:  BMC Dev Biol       Date:  2009-06-18       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.